BIMZELX® (BIMEKIZUMAB-BKZX) TWO-YEAR DATA AT AAD SHOWED POTENTIAL TO ELIMINATE DRAINING TUNNELS IN HIDRADENITIS SUPPURATIVA, AND REDUCTION IN DISEASE BURDEN
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.